Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota

Pediatric Allergy and Immunology

Volumn 23, Issue 3, 2012, Pages 255-258

  Ismail, Intan H ^a,b   Oppedisano, Frances ^a   Joseph, Shayne J ^b   Boyle, Robert J ^a,b,c   Robins Browne, Roy M ^a,b,d   Tang, Mimi L K ^a,b,d  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Diversity; Gut microbiota; Lactobacillus rhamnosus; Terminal restriction fragment length polymorphism

Indexed keywords

LACTOBACILLUS RHAMNOSUS GG; PLACEBO; PROBIOTIC AGENT; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; BIFIDOBACTERIUM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECZEMA; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; PERINATAL PERIOD; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BACTERIA; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DOUBLE-BLIND METHOD; ECZEMA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; PRENATAL CARE; PROBIOTICS; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME;

EID: 84859809605     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2011.01239.x     Document Type: Article

References (12)

1. Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5years of age. Clin Exp Allergy 2009: 39: 518-26.
2. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007: 56: 661-7.
3. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007: 37: 506-11.
4. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007: 51: 260-9.
5. Adlerberth I, Strachan DP, Matricardi PM, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007: 120: 343-50.
6. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008: 121: 129-34.
7. Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010: 22: 626-34.
8. Lahtinen SJ, Boyle RJ, Kivivuori S, et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 2009: 123: 499-501.e498.
9. Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011: 66: 509-16.
10. Zoetendal EG, Heilig HGHJ, Klaassens ES, et al. Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat Protoc 2006: 1: 870-3.
11. Osborne CA, Rees GN, Bernstein Y, Janssen PH. New threshold and confidence estimates for terminal restriction fragment length polymorphism analysis of complex bacterial communities. Appl Environ Microbiol 2006: 72: 1270-8.
12. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006: 118: 511-21.